WELLSTAT OPHTHALMICS CORP has a total of 23 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), United States and Brazil. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are FIT BIOTECH OY, AVIRON INC and 1GLOBE HEALTH INST LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 3 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Australia | 1 | |
#10 | Hong Kong | 1 | |
#11 | Israel | 1 | |
#12 | New Zealand | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Luo Tianci | 19 |
#2 | Zhang Jun | 8 |
#3 | Tianci Luo | 3 |
#4 | Kaleko Michael | 2 |
#5 | Jun Zhang | 2 |
Publication | Filing date | Title |
---|---|---|
CN109415423A | The fusion protein of short retinal rod source property cone Active factor and hydrophilic peptide | |
CA2853379A1 | Vectors encoding rod-derived cone viability factor |